I think it's fair to say that the ICIs are already
Post# of 158106
(Total Views: 287)
Posted On: 10/22/2025 8:23:20 AM
Re: KenChowder #158096
I think it's fair to say that the ICIs are already a part of the trial in the rollover study, so any talk of "inclusion", at least to me, means getting them into the main part of the study. Which would be fantastic.
I should also go on record that while I am very, very, very, very rich, most of my net worth is currently tied up in frozen concentrated orange juice futures. The individual helping out Cytodyn is hopefully one of my billionaire buddies like Gates (funds tons of research, Max could snag his ear) or Buffett (dropped almost $200 million into Biogen as they were trying to get Aduhelm to market).
I should note that Buffett helped Biogen by buying shares in Biogen via Berkshire Hathaway, which he did then sell once they got accelerated approval and he was in line to make a great profit. Not the same as just offering to cover some trials.
Also, I don't know how the ultra high net worth individual is going to be paying for the expanded access and glio trial, but perhaps that's what the shelf offering was/is specifically for? It was rushed into place and then has hung out ready and waiting ever since. And then wasn't there wording in the presentation about getting the details of the agreement with our UHNW individual done soon? So maybe they've been just a little slow in finalizing how that will all shake out but we get to find out soon once they have to use those shares and submit docs to the sec?
At some point all of these unnamed people and organizations are going to have to be revealed, no? In lieu of data-driven news, I can't think of anything better than the publicity that would come from a big name becoming publicly connected to CYDY.
That being said, it's probably some completely unknown guy worth $42 million in rural Washington that lost both parents to glioblastoma. Still amazing to get the support, but wouldn't move the needle.
I'm hoping for needle-moving shit from here on out.
I should also go on record that while I am very, very, very, very rich, most of my net worth is currently tied up in frozen concentrated orange juice futures. The individual helping out Cytodyn is hopefully one of my billionaire buddies like Gates (funds tons of research, Max could snag his ear) or Buffett (dropped almost $200 million into Biogen as they were trying to get Aduhelm to market).
I should note that Buffett helped Biogen by buying shares in Biogen via Berkshire Hathaway, which he did then sell once they got accelerated approval and he was in line to make a great profit. Not the same as just offering to cover some trials.
Also, I don't know how the ultra high net worth individual is going to be paying for the expanded access and glio trial, but perhaps that's what the shelf offering was/is specifically for? It was rushed into place and then has hung out ready and waiting ever since. And then wasn't there wording in the presentation about getting the details of the agreement with our UHNW individual done soon? So maybe they've been just a little slow in finalizing how that will all shake out but we get to find out soon once they have to use those shares and submit docs to the sec?
At some point all of these unnamed people and organizations are going to have to be revealed, no? In lieu of data-driven news, I can't think of anything better than the publicity that would come from a big name becoming publicly connected to CYDY.
That being said, it's probably some completely unknown guy worth $42 million in rural Washington that lost both parents to glioblastoma. Still amazing to get the support, but wouldn't move the needle.
I'm hoping for needle-moving shit from here on out.
(8)
(0)